Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial.
Saved in:
| Title: | Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial. |
|---|---|
| Authors: | Hao, Yun1 (AUTHOR), Xie, Fei2 (AUTHOR), Zhou, Yongjie3 (AUTHOR), Li, Chuan1 (AUTHOR), Zhang, Xiaoyun1 (AUTHOR), Shen, Junyi1 (AUTHOR), Yao, Minghong4 (AUTHOR), Sun, Xin4 (AUTHOR), Zhou, Jin1 (AUTHOR), Wen, Tianfu1 (AUTHOR), Peng, Wei1,4 (AUTHOR) pengwei@wchscu.edu.cn |
| Source: | Trials. 7/19/2024, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
